1. From Clinical Pharmacology, National Heart and Lung Institute, Imperial College of Science, Technology & Medicine, St. Mary’s Hospital, London (J.S.L., S.J.R., G.F.C., K.L.G., A.D.H.), and the Immunology Unit, Glaxo-Wellcome, Medicines Research Centre, Stevenage (C.N., N.T.T.), England.